Synopsys (SNPS)
(Delayed Data from NSDQ)
$561.55 USD
-12.04 (-2.10%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $561.71 +0.16 (0.03%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$561.55 USD
-12.04 (-2.10%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $561.71 +0.16 (0.03%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Zacks News
Should You Invest in the Invesco Dynamic Software ETF (PSJ)?
by Zacks Equity Research
Sector ETF report for PSJ
Buy These 5 Low Leverage Stocks to Invest Safely
by Zacks Equity Research
Debt financing is a feasible option as long as the companies succeed in generating a higher rate of return compared to the interest rate
5 Top-Ranked Nasdaq-Listed Tech Stocks to Buy Right Now
by Anirudha Bhagat
The rally in technology stocks has been aiding the Nasdaq Composite for the last two months. Here we choose five technology stocks that are well poised to grow as the U.S. economy partially reopens.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Synopsys, Acushnet, CrowdStrike, Zoom and Netflix highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Synopsys, Acushnet, CrowdStrike, Zoom and Netflix highlighted as Zacks Bull and Bear of the Day
Bull Of The Day: Synopsys (SNPS)
by Daniel Laboe
Synopsys is the backbone of innovation for global electronics and a safe way to invest in the impending 5G revolution and the resurgence in hyperscale computing
Autodesk (ADSK) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Autodesk (ADSK) first-quarter fiscal 2021 results reflect higher subscription revenues, gross margin expansion and lower operating expenses despite softness in software spending.
The Zacks Analyst Blog Highlights: NIKE, Workday, Allstate, Synopsys and HP
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NIKE, Workday, Allstate, Synopsys and HP
SNPS or INTU: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SNPS vs. INTU: Which Stock Is the Better Value Option?
Synopsys (SNPS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Synopsys (SNPS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Company News for May 22, 2020
by Zacks Equity Research
Companies In The News Are: MDT, BJ, SNPS, EXPE.
Top Analyst Reports for NIKE, Workday & Allstate
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NIKE (NKE), Workday (WDAY) and Allstate (ALL).
Synopsys' (SNPS) Q2 Earnings and Revenues Surpass Estimates
by Zacks.com
Synopsys' (SNPS) second-quarter fiscal 2020 results benefit from strong design wins owing to a robust product portfolio.
Synopsys (SNPS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 23.23% and 2.92%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Synopsys (SNPS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Synopsys (SNPS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Has Synopsys (SNPS) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (SNPS) Outperforming Other Computer and Technology Stocks This Year?
Tech Stocks' Earnings Lineup This Week: PANW, INTU & More
by Anirudha Bhagat
Here we take a sneak peek at five tech stocks lined up to report quarterly earnings this week.
Synopsys (SNPS) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Synopsys' (SNPS) second-quarter fiscal 2020 results likely to reflect benefits from strong demand for its solid product portfolio.
Analysts Estimate Synopsys (SNPS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Synopsys (SNPS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Amkor (AMKR) Gears Up for Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Healthy growth in the industrial and automotive end market is likely to reflect on Amkor Technology's (AMKR) first-quarter results. However, uncertainty owing to coronavirus outbreak may have been a concern.
What's in Store for STMicroelectronics' (STM) Q1 Earnings?
by Zacks Equity Research
STMicroelectronics' (STM) Q1 results may be affected by weakness in some of the end-markets served and uncertainty owing to coronavirus outbreak.
Lam Research (LRCX) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Lam Research's (LRCX) fiscal third-quarter results are likely to reflect the global coronavirus-driven economic crisis.
What's in Store for Texas Instruments' (TXN) Q1 Earnings?
by Zacks Equity Research
Weakness in overall demand due to COVID-19 pandemic, and increased competition in the auto and industrial space are likely to reflect on Texas Instruments' Q1 results.
Zacks.com featured highlights include: Regency Centers, ResMed, Synopsys, Cboe Global Markets and The Southern Company
by Zacks Equity Research
Zacks.com featured highlights include: Regency Centers, ResMed, Synopsys, Cboe Global Markets and The Southern Company